Namendamemantine
According to the FDA label: Memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine hydrochloride tablets are an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. (1)
13,229 adverse event reports submitted to the FDA (2004–2026)
Top Reported Adverse Events
The most frequently reported events in association with Namenda in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.
Show these terms with plain-language definitions
Tap any term below for a plain-language definition.
Fall 963 reports
A report that the person fell down. Falls are tracked because they can signal issues like dizziness, weakness, or balance problems.
Full definition in the glossary →Death 892 reports
A report that the person died. A death appearing in reports for a drug does not mean the drug caused it. Reports record that a death occurred while the medication was being used, which can happen for many unrelated reasons.
Full definition in the glossary →Drug Ineffective 836 reports
A report that the medication did not work as expected for the person taking it. This is a reporting category, not a sign the drug is defective. It simply means someone felt it was not helping their condition.
Full definition in the glossary →Off Label Use 758 reports
Using a medication for a condition or in a way that the FDA has not officially approved. This is common and often legal, and a report of it does not mean something went wrong. Doctors sometimes prescribe drugs off label based on their judgment.
Full definition in the glossary →Confusional State 718 reports
A state of being confused, disoriented, or unable to think clearly.
Full definition in the glossary →Fatigue 622 reports
Extreme tiredness or lack of energy that does not improve with rest.
Full definition in the glossary → See all drugs reporting this event →Hallucination 605 reports
Seeing, hearing, or sensing things that are not actually there. The term records what was reported and does not establish that a medication was the cause.
Full definition in the glossary →Condition Aggravated 511 reports
A report that the person's existing health condition got worse. This describes a worsening of something the person already had, not necessarily a new problem caused by the drug.
Full definition in the glossary →Asthenia 479 reports
Physical weakness or lack of strength.
Full definition in the glossary →Dizziness 451 reports
A feeling of being lightheaded, unsteady, or like the room is spinning.
Full definition in the glossary → See all drugs reporting this event →Somnolence 451 reports
Drowsiness or strong sleepiness.
Full definition in the glossary → See all drugs reporting this event →Urinary Tract Infection 430 reports
An infection in the bladder, urethra, or kidneys, often called a UTI.
Full definition in the glossary → See all drugs reporting this event →Nausea 411 reports
The feeling of sickness in your stomach that often comes before vomiting.
Full definition in the glossary → See all drugs reporting this event →Diarrhoea 390 reports
Loose or watery bowel movements, often frequent. Also spelled diarrhea in American English.
Full definition in the glossary → See all drugs reporting this event →Product Dose Omission Issue 354 reports
A report that a dose of the medication was missed or skipped.
Full definition in the glossary →
Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.
Who Is Reporting
Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.
By Sex
View reporter sex data as a table
| Sex | Reports |
|---|---|
| Female | 6,158 |
| Male | 5,723 |
| Unknown | 8 |
By Age Group
View age group data as a table
| Age group | Reports |
|---|---|
| 0-17 | 186 |
| 18-34 | 248 |
| 35-49 | 341 |
| 50-64 | 1,076 |
| 65-74 | 1,891 |
| 75+ | 5,818 |
This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.
Reported Outcomes
Outcomes recorded in FAERS reports that included Namenda. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.
View outcome data as a table
| Outcome | Reports |
|---|---|
| Other Serious | 6,388 |
| Hospitalization | 5,382 |
| Non-Serious | 2,579 |
| Death | 2,036 |
| Life-Threatening | 570 |
| Disability | 428 |
Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.
Report Volume Over Time
Number of FAERS reports received per quarter for Namenda. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.
View report trend as a table
| Year | Reports |
|---|---|
| 2004 | 22 |
| 2005 | 20 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 29 |
| 2010 | 101 |
| 2011 | 354 |
| 2012 | 310 |
| 2013 | 226 |
| 2014 | 278 |
| 2015 | 414 |
| 2016 | 626 |
| 2017 | 801 |
| 2018 | 872 |
| 2019 | 966 |
| 2020 | 1,119 |
| 2021 | 1,108 |
| 2022 | 1,345 |
| 2023 | 1,291 |
| 2024 | 1,485 |
| 2025 | 1,491 |
| 2026 (partial) | 369 |
The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.
Medications commonly reported with Namenda
In FDA adverse event reports that mention Namenda, these medications appeared most often in the same report.
- Donepezil (3,059 reports)
- Aspirin (1,863 reports)
- Quetiapine (1,636 reports)
- Pimavanserin (1,491 reports)
- Ergocalciferol (1,271 reports)
This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.
Related Drugs
Other medications with similar adverse event profiles in FDA FAERS reports.
Data Source
This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.
View this data on the FDA website →Data last updated: June 2026